FGF15 promotes hepatic NPC1L1 degradation in lithogenic diet-fed mice

Pingfan Mo,Hongtan Chen,Xin Jiang,Fengling Hu,Fenming Zhang,Guodong Shan,Wenguo Chen,Sha Li,Yiqiao Li,Guoqiang Xu

DOI: https://doi.org/10.1186/s12944-022-01709-8

2022-10-09

Lipids in Health and Disease

Abstract:Cholesterol gallstone disease (CGD) is accompanied by biliary cholesterol supersaturation. Hepatic Niemann-Pick C1-like 1 (NPC1L1), which is present in humans but not in wild-type (WT) mice, promotes hepatocyte cholesterol uptake and decreases biliary cholesterol supersaturation. In contrast, intestinal NPC1L1 promotes intestinal cholesterol absorption, increasing biliary cholesterol supersaturation. Ezetimibe (EZE) can inhibit both hepatic and intestinal NPC1L1. However, whether hepatic NPC1L1 can affect CGD progress remains unknown.

biochemistry & molecular biology,nutrition & dietetics